Search filters

List of works by Norbert Vey

A randomized phase II trial of azacitidine +/- epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents

scientific article published on 26 May 2016

Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies

scientific article published on 18 March 2016

Acute myeloid leukemia with myelodysplasia‐related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations ⬇️

scientific article published on April 25, 2012

Allogeneic hematopoietic cell transplantation following the use of hypomethylating agents among patients with relapsed or refractory AML: Findings from an international retrospective study.

scientific article published on 9 April 2018

Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire ⬇️

scientific article published on March 7, 2013

Alteration of cohesin genes in myeloid diseases ⬇️

scientific article published on September 1, 2010

Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) ⬇️

scientific article published on March 15, 2013

Azacitidine in untreated acute myeloid leukemia: a report on 149 patients

scientific article published on 06 February 2014

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

scientific article

Bortezomib combined with low‐dose cytarabine in Intermediate‐2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM ⬇️

scientific article published on May 10, 2012

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

scientific article

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity

scientific article published on 24 March 2014

Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation

scientific article published on 01 December 1997

Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype

scientific article published on 30 December 2019

Current management of myelodysplastic syndromes

scientific article published on December 20, 2010

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT ⬇️

scientific article published on June 10, 2013

Elacytarabine has single‐agent activity in patients with advanced acute myeloid leukaemia ⬇️

scientific article published on June 15, 2012

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS ⬇️

scientific article published on July 30, 2011

Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia

article

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

scientific article published on 01 April 2018

Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches

scientific article published on August 1, 2003

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia

scientific article

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

scientific article published on 18 September 2020

Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia

scientific article published on 18 March 2020

Massive ascites of donor T-cell origin in a patient with acute GVHD after a reduced-intensity allograft for CLL ⬇️

scientific article published on 01 November 2003

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial.

scientific article

Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms ⬇️

scientific article published on April 9, 2012

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes.

scientific article

Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms ⬇️

scientific article published on August 26, 2011

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

scientific article published on 10 May 2017

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

scientific article

Nelarabine for T Cell Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: An Opportunity to Improve Survival ⬇️

scientific article published on May 3, 2013

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure ⬇️

scientific article published on July 25, 2011

Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure.

scientific article published on 06 March 2012

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

scientific article published on 02 July 2018

Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia

scholarly article by Farhad Ravandi et al published November 2018 in Haematologica

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.

scientific article

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.

scientific article published on 12 October 2010

Prognostic score including gene mutations in chronic myelomonocytic leukemia.

scientific article

Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trial

scientific article published on 11 January 2018

Second Neoplasms Following High-dose Chemotherapy and Autologous Stem Cell Transplantation for Malignant Lymphomas: A Report of Six Cases in a Cohort of 171 Patients from a Single Institution ⬇️

scientific article published on 01 September 1998

Survey of Early Disapearance of BCR/ABL Fusion Transcript after Allogeneic or Autologous Stem Cell Transplantation for Chronic Myelogenous Leukemia ⬇️

scientific article published on 01 September 2001

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

scientific article published on October 2009

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

scientific article

Targeting Age-Related Changes in the Biology of Acute Myeloid Leukemia: Is the Patient Seeing the Progress? ⬇️

scientific article published on January 17, 2013

The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience

scientific article published on 01 December 2012

Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

scientific article

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

scientific article published on 30 July 2015

l‐asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005‐01 randomized trial ⬇️

scientific article published on February 20, 2011

Paulina is supported by:

About Paulina

Help